Compare ACMR & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACMR | STVN |
|---|---|---|
| Founded | 1998 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.2B |
| IPO Year | 2017 | 2021 |
| Metric | ACMR | STVN |
|---|---|---|
| Price | $49.15 | $19.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $115.33 | $24.47 |
| AVG Volume (30 Days) | ★ 1.2M | 281.8K |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 0.33% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $74,643,000.00 | N/A |
| Revenue This Year | $29.84 | $6.96 |
| Revenue Next Year | $29.18 | $9.15 |
| P/E Ratio | $36.58 | ★ $27.15 |
| Revenue Growth | ★ 104.47 | N/A |
| 52 Week Low | $28.46 | $12.89 |
| 52 Week High | $127.19 | $27.99 |
| Indicator | ACMR | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 26.43 | 44.76 |
| Support Level | $47.48 | $18.87 |
| Resistance Level | $57.27 | $20.02 |
| Average True Range (ATR) | 3.72 | 0.64 |
| MACD | -2.07 | -0.01 |
| Stochastic Oscillator | 2.06 | 43.34 |
ACM Research Inc supplies capital equipment developed for the semiconductor industry. The company focuses on developing differentiated process solutions that enable effective particle removal, uniform material deposition, and reliable process control for the fabricators of integrated circuits. Its product offerings include wet-cleaning, plating, furnace, PECVD, track, and other front-end processing equipment. Additionally, it develops, manufactures, and sells a range of packaging equipment to wafer assembly and packaging customers. Geographically, the company generates maximum revenue from its customers in Mainland China, and the rest from other regions.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.